A Novel Ginsenoside-Transforming α-L-Rhamnosidase from Bifidobacterium: Screening, Characterization and Application
Biomolecules · 2024
DOI: 10.3390/biom14121611 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomolecules, 2024. Verfasst von Chang-Hao Cui und 3 weiteren Autor:innen. Beteiligte Einrichtung: Sempio Fermentation Research Center, Sempio Foods Company, Osong 28156, Republic of Korea. Hauptthemen laut MEDLINE: Ginsenosides, Glycoside Hydrolases, Bifidobacterium. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Korea Institute of Planning and Evaluation for Technology in Food, Agriculture, Forestry and Fisheries, Korea Institute of Planning and Evaluation for Technology in Food, Agriculture and Forestry (IPET).
Abstract (Originalsprache)
Despite the rapid advancement of glycosidase biotechnology, ginsenoside-transforming rhamnosidases remain underexplored due to a lack of research. In this study, we aimed to bridge this gap by evaluating eight putative rhamnosidases for their ability to transform ginsenosides. Among them, a novel rhamnosidase (C118) from Bifidobacterium was identified as being efficient at hydrolyzing ginsenoside Re. This enzyme was expressed well in Escherichia coli and exhibited optimal activity at pH of 6.0 and 45 °C. Protein structural predictions revealed that the potential active hydrophobic area near an active pocket may influence the ginsenoside-transforming activities compared to non-active screened rhamnosidases. This enzyme’s thermal stability exceeded that of the only previously known ginsenoside-transforming rhamnosidase, BD890. Additionally, the kcat/Km value of C118 was 1.45 times higher than that of BD890. Using recombinant C118 from E. coli, all ginsenoside Re in a PPT-type ginsenoside mixture (2.25 mg/mL) was converted after 12 h of reaction. To the best of our knowledge, this is the most efficient ginsenoside Re-transforming α-L-rhamnosidase reported to date, enhancing our understanding of rhamnosidase–substrate interactions and potentially improving the efficiency and specificity of the conversion process. These findings offer promising implications for the production of pharmacologically active ginsenosides in the pharmaceutical, cosmetic, and functional food industries.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Sempio Fermentation Research Center, Sempio Foods Company, Osong 28156, Republic of Korea.
- Department of Biotechnology, Hankyong National University, Anseong 17579, Republic of Korea.
- AceEMzyme Co., Ltd., Academic Industry Cooperation, Anseong 17579, Republic of Korea.
Förderung
- Korea Institute of Planning and Evaluation for Technology in Food, Agriculture, Forestry and Fisheries
- Korea Institute of Planning and Evaluation for Technology in Food, Agriculture and Forestry (IPET)
Zitieren
APA
Cui, C. H., Shin, D., Hurh, B. S., & Im, W. T. (2024). A Novel Ginsenoside-Transforming α-L-Rhamnosidase from Bifidobacterium: Screening, Characterization and Application. Biomolecules. https://doi.org/10.3390/biom14121611
Vancouver
Cui CH, Shin D, Hurh BS, Im WT. A Novel Ginsenoside-Transforming α-L-Rhamnosidase from Bifidobacterium: Screening, Characterization and Application. Biomolecules. 2024. doi:10.3390/biom14121611
BibTeX
@article{Cui2024,
author = {Cui, Chang-Hao and Shin, Doohang and Hurh, Byung-Serk and Im, Wan-Taek},
title = {A Novel Ginsenoside-Transforming α-L-Rhamnosidase from Bifidobacterium: Screening, Characterization and Application},
journal = {Biomolecules},
year = {2024},
doi = {10.3390/biom14121611}
}
EUVIMED